A short segment in the HIV-1 gp120 V1/V2 region is a major determinant of neutralization resistance to PG9-like antibodies
Publication
, Journal Article
Doria-Rose, NA; Georgiev, I; Staupe, RP; O'Dell, S; Chuang, G; Gorman, J; McLellan, JS; Pancera, M; Bonsignori, M; Haynes, BF; Burton, DR ...
Published in: RETROVIROLOGY
2012
Duke Scholars
Published In
RETROVIROLOGY
DOI
ISSN
1742-4690
Publication Date
2012
Volume
9
Related Subject Headings
- Virology
- 3107 Microbiology
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Doria-Rose, N. A., Georgiev, I., Staupe, R. P., O’Dell, S., Chuang, G., Gorman, J., … Mascola, J. R. (2012). A short segment in the HIV-1 gp120 V1/V2 region is a major determinant of neutralization resistance to PG9-like antibodies. RETROVIROLOGY, 9. https://doi.org/10.1186/1742-4690-9-S2-O29
Doria-Rose, N. A., I. Georgiev, R. P. Staupe, S. O’Dell, G. Chuang, J. Gorman, J. S. McLellan, et al. “A short segment in the HIV-1 gp120 V1/V2 region is a major determinant of neutralization resistance to PG9-like antibodies.” RETROVIROLOGY 9 (2012). https://doi.org/10.1186/1742-4690-9-S2-O29.
Doria-Rose NA, Georgiev I, Staupe RP, O’Dell S, Chuang G, Gorman J, et al. A short segment in the HIV-1 gp120 V1/V2 region is a major determinant of neutralization resistance to PG9-like antibodies. RETROVIROLOGY. 2012;9.
Doria-Rose, N. A., et al. “A short segment in the HIV-1 gp120 V1/V2 region is a major determinant of neutralization resistance to PG9-like antibodies.” RETROVIROLOGY, vol. 9, 2012. Wos-lite, doi:10.1186/1742-4690-9-S2-O29.
Doria-Rose NA, Georgiev I, Staupe RP, O’Dell S, Chuang G, Gorman J, McLellan JS, Pancera M, Bonsignori M, Haynes BF, Burton DR, Koff WC, Kwong PD, Mascola JR. A short segment in the HIV-1 gp120 V1/V2 region is a major determinant of neutralization resistance to PG9-like antibodies. RETROVIROLOGY. 2012;9.
Published In
RETROVIROLOGY
DOI
ISSN
1742-4690
Publication Date
2012
Volume
9
Related Subject Headings
- Virology
- 3107 Microbiology
- 1103 Clinical Sciences